ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Company Registration Number:
07643613 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 01 June 2022

End date: 31 May 2023

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Contents of the Financial Statements

for the Period Ended 31 May 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Company Information

for the Period Ended 31 May 2023




Director: Adetoyese Shodeinde
Registered office: 31
Marshall Close
Purley On Thames
Reading
England
RG8 8DQ
Company Registration Number: 07643613 (England and Wales)

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Directors' Report Period Ended 31 May 2023

The directors present their report with the financial statements of the company for the period ended 31 May 2023

Principal Activities

The company's principal activity during the year continued to be wholesale of pharmaceutical goods.

Directors

The directors shown below have held office during the whole of the period from 01 June 2022 to 31 May 2023
Adetoyese Shodeinde

This report was approved by the board of directors on 25 January 2024
And Signed On Behalf Of The Board By:

Name: Adetoyese Shodeinde
Status: Director

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Profit and Loss Account

for the Period Ended 31 May 2023


Notes

2023
£

2022
£
Turnover 183,146 212,634
Cost of sales ( 2,728 ) ( 134,023 )
Gross Profit or (Loss) 180,418 78,611
Administrative Expenses ( 119,968 ) ( 123,446 )
Operating Profit or (Loss) 60,450 ( 44,835 )
Profit or (Loss) Before Tax 60,450 ( 44,835 )
Tax on Profit ( 7,204 ) -
Profit or (Loss) for Period 53,246 ( 44,835 )

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Balance sheet

As at 31 May 2023


Notes

2023
£

2022
£
Fixed assets
Tangible assets: 4 54,655 65,610
Total fixed assets: 54,655 65,610
Current assets
Debtors: 5 42,168
Cash at bank and in hand: 1,258 24
Total current assets: 43,426 24
Creditors: amounts falling due within one year: 6 ( 40,936 ) ( 50,748 )
Net current assets (liabilities): 2,490 ( 50,724 )
Total assets less current liabilities: 57,145 14,886
Creditors: amounts falling due after more than one year: 7 ( 37,389 ) ( 48,376 )
Total net assets (liabilities): 19,756 ( 33,490 )

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Balance sheet continued

As at 31 May 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 19,755 ( 33,491 )
Shareholders funds: 19,756 ( 33,490 )

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 25 January 2024
And Signed On Behalf Of The Board By:

Name: Adetoyese Shodeinde
Status: Director

The notes form part of these financial statements

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
    Fixtures, fittings, tools and equipment over 5 years

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 2 2

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 3. Off balance sheet disclosure

    No

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

4. Tangible assets

Office equipment Motor vehicles Total
Cost £ £ £
At 01 June 2022 18,697 82,607 101,304
Additions - - -
Disposals - - -
Revaluations - - -
Transfers - - -
At 31 May 2023 18,697 82,607 101,304
Depreciation
At 01 June 2022 13,248 22,446 35,694
Charge for year 2,640 8,315 10,955
On disposals - - -
Other adjustments - - -
At 31 May 2023 15,888 30,761 46,649
Net book value
At 31 May 2023 2,809 51,846 54,655
At 31 May 2022 5,449 60,161 65,610

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

5. Debtors


2023
£

2022
£
Trade debtors 42,168
Total 42,168

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

6.Creditors: amounts falling due within one year note


2023
£

2022
£
Bank loans and overdrafts 4,172
Trade creditors 12,213 4,200
Taxation and social security 13,512 12,601
Other creditors 15,211 29,775
Total 40,936 50,748

ASH BIOMEDICAL INTEGRATED SERVICES LIMITED

Notes to the Financial Statements

for the Period Ended 31 May 2023

7.Creditors: amounts falling due after more than one year


2023
£

2022
£
Bank loans and overdrafts 37,389 48,376
Total 37,389 48,376